Ansbert Gadicke - Director, 10%+ Owner at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
KLRS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ansbert Gadicke since 10/27/2024

Holdings reported by Ansbert Gadicke for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16.7M $11.2M $0.67 Jul 28, 2022 By ElevateBio LLC
Common Stock 30.2K $20.3K $0.67 Jul 28, 2022 Direct
Stock Option (Right to Buy) 27.5K May 17, 2022 Direct Common Stock

Transactions reported by Ansbert Gadicke for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.